| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 339 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 334 |
| 2 | TACROLIMUS OINTMENT 0.1% | 334 |
| 3 | MYCOPHENOLATE MOFETIL | 296 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 296 |
| 5 | PREDNISONE | 243 |
| 6 | GANCICLOVIR | 108 |
| 7 | GANCICLOVIR SODIUM | 108 |
| 8 | CYCLOSPORINE | 105 |
| 9 | RITUXIMAB | 100 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACYCLOVIR SODIUM | 16 | 0.0127 |
| 1 | GANCICLOVIR SODIUM | 108 | 0.0101 |
| 2 | SIROLIMUS | 90 | 0.0066 |
| 3 | FAMCICLOVIR | 12 | 0.0043 |
| 4 | VALGANCICLOVIR | 57 | 0.0030 |
| 5 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 17 | 0.0026 |
| 6 | TACROLIMUS OINTMENT 0.1% | 334 | 0.0026 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 334 | 0.0026 |
| 8 | MYCOPHENOLATE MOFETIL | 296 | 0.0021 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 296 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 136 | 0.0061 |
| 1 | Nucleoside Analog Antiviral [EPC] | 108 | 0.0013 |
| 2 | Human Immunoglobulin G [EPC] | 26 | 0.0012 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 107 | 0.0008 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 15 | 0.0007 |
| 5 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 69 | 0.0006 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 58 | 0.0005 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 100 | 0.0003 |
| 9 | Alkylating Drug [EPC] | 72 | 0.0003 |